Jubilant Biosys, a collaborative drug discovery specialist headquartered in India, has made two new leadership appointments with the aim of expanding its global reach and exploring new business opportunities.
Steven Hutchins has been appointed as President, while Dr Takeshi Yura becomes Vice President of Medicinal Chemistry.
Hutchins brings 26 years of pharmaceutical & healthcare experience and leadership to Jubilant, including experience in Business Development, R&D, as well as forming strategic partnerships.
He has held senior management positions at Merck, BioDuro, WuXi AppTec, and Evotec where he led the development of strategy, sales & marketing and commercialisation of key strategic alliances.
Yura has 28 years of experience in medicinal and organic chemistry.
Takeshi Yura
He has held various scientific positions at Tanabe Saiyaku, Bayer Yakuhin, Pfizer Nagoya Laboratories and Dishman Japan.
Before joining Jubilant, he was Vice President of Discovery and Development Services for Asia and General Manager for Singapore Research centre at AMRI.
